Muted

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) shareholders would be thrilled to see that the share price tag has had a wonderful month, putting up a  acquire and recovering from prior weakness. Getting a wider view, although not as solid as the previous thirty day period, the full year get of  is also […]